Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Articles

Liver Imaging

Chemotherapy induced liver abnormalities: an imaging perspective

Clinical and Molecular Hepatology 2014;20(3):317-326.
Published online: September 25, 2014

1Department of Internal Medicine, University of California, Irvine, Orange, CA, USA.

2Department of Radiological Sciences, University of California, Irvine, Orange, CA, USA.

3Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

4Department of Radiology, Seoul St.Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Corresponding author: Ankush Sharma. Department of Internal Medicine, University of California, Irvine, Orange, CA, 3347 S Alton Ct Santa Ana, CA 92704, USA. Tel: +1-213-709-3930, Fax: +1-714-456-7182, ankushs@hs.uci.edu

Copyright © 2014 by The Korean Association for the Study of the Liver

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 26,860 Views
  • 361 Download
  • 80 Web of Science
  • 75 Crossref
  • 86 Scopus
prev

Citations

Citations to this article as recorded by  Crossref logo
  • Schwanger werden nach Mamma- oder Genitalkarzinom – Wann darf ich mich trauen?
    Julia Téoule, Karin Bundschu, Katharina Hancke
    Die Gynäkologie.2026; 59(2): 105.     CrossRef
  • Therapeutic potential and pharmacological mechanisms of cannabinoids in alleviating chemotherapy-induced organ toxicity and adverse effects
    Bushra Zia, M.F. Nagoor Meeran, Charu Sharma, Sameer Mirza, Shreesh K. Ojha
    European Journal of Pharmacology.2026; 1017: 178646.     CrossRef
  • Quantifying Functional Liver Volume Loss after CT-guided Percutaneous Thermal Ablation: A COVER-ALL Trial Post Hoc Analysis
    Noreen S. Siddiqi, Jessica Albuquerque, Iwan Paolucci, Yuan-Mao Lin, Caleb O’Connor, Antony Haddad, Aaron K. Jones, Jean-Nicholas Vauthey, Kristy K. Brock, Bruno C. Odisio
    Radiology: Imaging Cancer.2026;[Epub]     CrossRef
  • Infiltrative liver conditions: a pictorial review of malignant and benign entities
    Jordan Zheng Ting Sim, Nicole Kessa Wee, Hsien Min Low
    Singapore Medical Journal.2026; 67(3): 184.     CrossRef
  • Hepatoprotective effects of Ulva fasciata against cisplatin-induced liver injury in rats: GC–MS-based identification, In Silico ADME profiling, and molecular docking analysis of bioactive compounds
    Nida Sohail, Muhammad Bilal Azmi, Hafiza Farhat, Kanwal Khan, Faizah Urooj, Bilal Ahmad Ghalloo, Shamim Akhtar Qureshi
    Computers in Biology and Medicine.2026; 213: 111804.     CrossRef
  • Metabolic remodelling in anthracycline cardiotoxicity: mechanisms and therapeutic insights
    Giulia Guerra, Francesco Niro, Marco Mergiotti, Giovanni Gavatorta, Emilio Hirsch, Alessandra Ghigo
    British Journal of Pharmacology.2026;[Epub]     CrossRef
  • Obeticholic Acid and Edaravone Protect Against Cisplatin‐Induced Hepatotoxicity Through Modulation of Keap1/Nrf2/ARE, TNF‐α/NF‐κB, and AKT/GSK‐3β Pathways
    Fares E. M. Ali, Adel G. Bakr, Abdel‐Gawad S. Shalkami, Ehab A. M. El‐Shoura, Lamiaa Khalaf Ahmed, Ali F. Abd‐Elsalam, Ahmed A. N. Ahmed, Emad H. M. Hassanein
    Journal of Biochemical and Molecular Toxicology.2026;[Epub]     CrossRef
  • Hepatoprotective effects of phytochemicals and plant extracts against chemotherapy-induced liver damage in animal models: a systematic review
    Jignesh Prajapati, Narendra Bhatt, Rakesh Rawal
    Archives of Toxicology.2025; 99(3): 887.     CrossRef
  • Negative impact of chemotherapy on kinetic growth rate of the future liver remnant if applied following PVE or ALPPS
    Klara Welcker, Martin A. Schneider, Tim Reese, Andrea Ehrenfeld, Hauke Weilert, Axel Stang, Peter Wohlmuth, Mia-Maria Warnke, Carolin Reiner, Thomas von Hahn, Karl J. Oldhafer, Andreas H. Mahnken, Roland Brüning, Gregory Tiao
    PLOS ONE.2025; 20(3): e0307937.     CrossRef
  • Pregnancy after cancer: FIGO Best practice advice
    Cynthia Maxwell, Sumaiya Adam, Lina Bergman, Surabhi Nanda, Valerie Tiempo Guinto, Noa Popovits‐Hadari, Maisah Al‐Bakri, Ifeyinwa Nwokoro, Fionnuala McAuliffe, Inge Peters, Catherine Nelson‐Piercy, Frederic Amant, Melanie Nana, Graeme Smith, Jonathan Bere
    International Journal of Gynecology & Obstetrics.2025; 169(3): 1119.     CrossRef
  • Coagulation profiles of breast cancer patients attending at cancer treatment centres in Northwest Ethiopia 2023: a comparative cross-sectional study
    Sisay Ayana, Melak Aynalem, Tiruneh Adane, Elias Shiferaw
    Scientific Reports.2025;[Epub]     CrossRef
  • Imaging findings of post-chemotherapy non-metastatic hepatic parenchymal changes
    San Yu Leung, Wing Tung Chiu, Matthew Ka Ki Law, Ho Ching Amy Wong, Alta Lai, Yiu Shiobhon Luk
    Journal of Clinical Imaging Science.2025; 15: 24.     CrossRef
  • Repurposing edaravone in oncology: Bridging antioxidant defense and immune modulation
    Sara I. Ibrahim, Dana M. Zaher, Fatema A. Hersi, Alaa O. Hamouda, Manar A. Al Hindawi, Hany A. Omar
    International Immunopharmacology.2025; 164: 115413.     CrossRef
  • Proteomic profiling reveals the molecular signatures of chemotherapy-induced human ovarian damage
    Johanne Grosbois, Xavier Bisteau, Virginie Imbault, Louise Conrard, Margherita Condorelli, Necati Findikli, Pascale Lybaert, Isabelle Demeestere
    Human Reproduction.2025; 40(12): 2395.     CrossRef
  • Recent advances in stimuli-responsive tailored nanogels for cancer therapy; from bench to personalized treatment
    Prinsy Rana, Charan Singh, Ajeet Kaushik, Shakir Saleem, Arun Kumar
    Journal of Materials Chemistry B.2024; 12(2): 382.     CrossRef
  • Efficacy and Safety of Metronomic Capecitabine in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
    Nandini Gupta, Neelkant Verma, Bhoomika Patel
    Journal of Gastrointestinal Cancer.2024; 55(4): 1485.     CrossRef
  • Efficacy of concomitant therapy with ademetionine in antitumor drug therapy: A review
    Nikolai A. Ognerubov
    Consilium Medicum.2024; 26(6): 351.     CrossRef
  • CEUS compared with CECT, MRI, and FDG-PET/CT for diagnosing CRC liver metastases: a diagnostic test accuracy systematic review and meta-analysis
    Martin Lund, Thomas A. Bjerre, Henning Grønbæk, Frank V. Mortensen, Per Kragh Andersen
    Expert Review of Gastroenterology & Hepatology.2024; 18(9): 541.     CrossRef
  • Application of Nanoparticles in the Diagnosis and Treatment of Colorectal Cancer
    Qiuyu Song, Yifeng Zheng, Guoqiang Zhong, Shanping Wang, Chengcheng He, Mingsong Li
    Anti-Cancer Agents in Medicinal Chemistry.2024; 24(18): 1305.     CrossRef
  • Imaging of body complications in pediatric oncology: a review of the literature and our experience
    Valentina Cariello, Patrizia Lombardo, Diana Baldari, Maria Cristina Smaldone, Paolo Pizzicato, Antonio Rossi, Luca Brunese, Giuseppe Paviglianiti, Maria Chiara Brunese, Rocco Minelli, Eugenio Rossi
    Journal of Medical Imaging and Interventional Radiology.2024;[Epub]     CrossRef
  • MRI findings of newly present benign focal hepatic observations following chemotherapy: distinct features in early- and late-term follow-up
    Yiqi Wang, Siyue Mao, Runqian Huang, Sheng Li, Rongzhen Luo, Jingxian Shen
    European Radiology.2024; 35(5): 2783.     CrossRef
  • Liver Dysfunction After Use of Nathanson Retractor During Laparoscopic Gastrectomy for Gastric Cancer
    Serdar Culcu, Selim Tamam, Cem Azili, Siyar Ersoz, Baris Morkavuk, Ali Ekrem Unal, Salim Demirci
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2023; 33(2): 205.     CrossRef
  • Concomitant Sub-Chronic Administration of Small-Size Gold Nanoparticles Aggravates Doxorubicin-Induced Liver Oxidative and Inflammatory Damage, Hyperlipidemia, and Hepatic Steatosis
    Ghedeir M. Alshammari, Mohamed Anwar Abdelhalim, Mohammed S. Al-Ayed, Laila Naif Al-Harbi, Mohammed Abdo Yahya
    Molecules.2023; 28(2): 796.     CrossRef
  • Therapeutic options in hepatocellular carcinoma: a comprehensive review
    Diwakar Suresh, Akshatha N. Srinivas, Akila Prashant, Kuzhuvelil B. Harikumar, Divya P. Kumar
    Clinical and Experimental Medicine.2023; 23(6): 1901.     CrossRef
  • Amelioration of cyclophosphamide-induced DNA damage, oxidative stress, and hepato- and neurotoxicity by Piper longum extract in rats: The role of γH2AX and 8-OHdG
    Vaishali Yadav, Anuja Krishnan, Sultan Zahiruddin, Sayeed Ahmad, Divya Vohora
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • Ring Enhancement in Non-Neoplastic Breast Tissue on MRI During Neoadjuvant Chemotherapy for Breast Cancer: Incidence and Clinical Implications
    Jiyun Oh, Boo-Kyung Han, Eun Y. Ko, Eun S. Ko, Ji S. Choi, Haejung Kim, Yeon H. Park, Ji-Yeon Kim
    Academic Radiology.2023; 30(12): 2931.     CrossRef
  • The Effect of Metformin on Chemotherapy-Induced Toxicities in Non-diabetic Breast Cancer Patients: A Randomised Controlled Study
    Manar A. Serageldin, Amira B. Kassem, Yasser El-Kerm, Maged W. Helmy, Mahmoud M. El-Mas, Noha A. El-Bassiouny
    Drug Safety.2023; 46(6): 587.     CrossRef
  • The role of ursodeoxycholic acid in the treatment of chemotherapy induced hepatotoxicity in the maintenance treatment of children with acute leukemia
    Özlem TERZİ, Ali AYÇİÇEK, Duygu YILDIRGAN, Hüseyin Avni SOLGUN, Sibel TEKGÜNDÜZ, Cengiz BAYRAM
    Family Practice and Palliative Care.2023; 8(4): 101.     CrossRef
  • Stereological Estimation and Zonal Distribution of the Hepatotoxic Effects of Doxorubicin on the Female Albino Rat (Rattus Norvegicus)
    Khulud Nurani, Anne Pulei, Beda Olabu, Jeremiah Munguti, Talha Chaudhry, Vincent Kipkorir
    International Journal of Medical Students.2023; 11(3): 184.     CrossRef
  • Clinical implications of chemotherapeutic agent organ toxicity on perioperative care
    Justin Zeien, Wendy Qiu, Mason Triay, Hemangini A. Dhaibar, Diana Cruz-Topete, Elyse M. Cornett, Ivan Urits, Omar Viswanath, Alan David Kaye
    Biomedicine & Pharmacotherapy.2022; 146: 112503.     CrossRef
  • Simple fabrication of multifunctional hyperbranched copolymer based on l-lysine and citric acid for co-delivery of anticancer drugs to breast cancer cells
    Robab Aslani, Hassan Namazi
    Reactive and Functional Polymers.2022; 170: 105101.     CrossRef
  • Liver Surgery: Important Considerations for Pre- and Postoperative Imaging
    Luisa Leitão de Faria, George Felipe Darce, André Leopoldino Bordini, Paulo Herman, Vagner Birk Jeismann, Iraí Santana de Oliveira, Cinthia D. Ortega, Manoel de Souza Rocha
    RadioGraphics.2022; 42(3): 722.     CrossRef
  • Cancer Treatment by Laser and Electrochemical Therapy Combined with Magnetic Nanoparticles as Potent Therapy Against Ehrlich Ascites Carcinoma
    Sahar E. Abo-Neima, Emad M. Elsehly
    BioNanoScience.2022; 12(3): 851.     CrossRef
  • Evaluation of liver function tests to identify hepatotoxicity among acute lymphoblastic leukemia patients who are receiving chemotherapy induction
    Ayal Tsegaye Mekonnen, Temesgen Gebeyehu Wondmeneh
    Scientific Reports.2022;[Epub]     CrossRef
  • Prognostic Factors for Overall Survival in Patients with HCV-Related HCC Undergoing Molecular Targeted Therapies: Beyond a Sustained Virological Response
    Yasunori Minami, Tomoko Aoki, Hirokazu Chishina, Masahiro Takita, Satoru Hagiwara, Hiroshi Ida, Kazuomi Ueshima, Naoshi Nishida, Masatoshi Kudo
    Cancers.2022; 14(19): 4850.     CrossRef
  • The Evidence Surrounding Non-Alcoholic Fatty Liver Disease in Individuals with Cancer: A Systematic Literature Review
    Elena S. George, Surbhi Sood, Nicole Kiss, Robin M. Daly, Amanda J. Nicoll, Stuart K. Roberts, Brenton J. Baguley
    Current Oncology.2022; 30(1): 48.     CrossRef
  • In Vivo Photodynamic Therapy With a Lipophilic Zinc(II) Phthalocyanine Inhibits Colorectal Cancer and Induces a Th1/CD8 Antitumor Immune Response
    Nicolás Chiarante, Maite Duhalde Vega, Federico Valli, Elsa Zotta, Hellen Daghero, Tatiana Basika, Mariela Bollati‐Fogolin, María C. García Vior, Julieta Marino, Leonor P. Roguin
    Lasers in Surgery and Medicine.2021; 53(3): 344.     CrossRef
  • Hepatic perfusional changes on CT and MRI: a radiology primer
    Dane Gunter, Shaista Riaz, Ehsan A. Haider, Ryan Rebello, Michael N. Patlas, Abdullah Alabousi
    Abdominal Radiology.2021; 46(1): 179.     CrossRef
  • Abdominal immune-related adverse events: detection on ultrasonography, CT, MRI and 18F-Fluorodeoxyglucose positron emission tomography
    Mark A Anderson, Vikram Kurra, William Bradley, Aoife Kilcoyne, Amirkasra Mojtahed, Susanna I Lee
    The British Journal of Radiology.2021;[Epub]     CrossRef
  • Muscle-Invasive Bladder Cancer in Patients with Liver Cirrhosis: A Review of Pertinent Considerations
    John Kim, Harkanwal Randhawa, David Sands, Shahid Lambe, Marco Puglia, Pablo E. Serrano, Jehonathan H. Pinthus
    Bladder Cancer.2021; 7(3): 261.     CrossRef
  • Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System
    Taurean Brown, DeLawrence Sykes, Antiño R. Allen
    Biomedicines.2021; 9(2): 189.     CrossRef
  • Preclinical Toxicity and Safety of MM-129—First-in-Class BTK/PD-L1 Inhibitor as a Potential Candidate against Colon Cancer
    Justyna Magdalena Hermanowicz, Bartlomiej Kalaska, Krystyna Pawlak, Beata Sieklucka, Joanna Miklosz, Mariusz Mojzych, Dariusz Pawlak
    Pharmaceutics.2021; 13(8): 1222.     CrossRef
  • Berberine—A potent chemosensitizer and chemoprotector to conventional cancer therapies
    Nalini Devarajan, Selvaraj Jayaraman, Jaideep Mahendra, Purushothaman Venkatratnam, Ponnulakshmi Rajagopal, Hema Palaniappan, Senthil Kumar Ganesan
    Phytotherapy Research.2021; 35(6): 3059.     CrossRef
  • Animal models of chemotherapy-induced cognitive decline in preclinical drug development
    Jeena John, Manas Kinra, Jayesh Mudgal, G. L. Viswanatha, K. Nandakumar
    Psychopharmacology.2021; 238(11): 3025.     CrossRef
  • Imaging of chemotherapy-induced liver toxicity: an illustrated overview
    Giovanni Brondani Torri, Matheus Dorigatti Soldatelli, Gustavo Felipe Luersen, Caroline Lorenzoni Almeida Ghezzi
    Hepatic Oncology.2021;[Epub]     CrossRef
  • Hydrazone conjugated and DOX loaded PEGylated-Fe3O4 mesoporous magnetic nanoclusters (MNCs): hyperthermia and in vitro chemotherapy
    Ahmaduddin Khan, Niroj Kumar Sahu
    New Journal of Chemistry.2021; 45(46): 21646.     CrossRef
  • Imaging of the chemotherapy-induced hepatic damage: Yellow liver, blue liver, and pseudocirrhosis
    Linda Calistri, Vieri Rastrelli, Cosimo Nardi, Davide Maraghelli, Sofia Vidali, Michele Pietragalla, Stefano Colagrande
    World Journal of Gastroenterology.2021; 27(46): 7866.     CrossRef
  • Cordyline fruticosa(L.) A. Chev. leaves: isolation, HPLC/MS profiling and evaluation of nephroprotective and hepatoprotective activities supported by molecular docking
    Mona A. Raslan, Rehab F. Taher, Ahmed A. Al-Karmalawy, Dalia El-Ebeedy, Angham G. Metwaly, Nourhan M. Elkateeb, Aml Ghanem, Reem A. Elghaish, Ahmed I. Abd El Maksoud
    New Journal of Chemistry.2021; 45(47): 22216.     CrossRef
  • Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report
    Tomohito Shinoda, Toshiyuki Tanahashi, Takuji Sakuratani, Masato Ota, Seito Fujibayashi, Shunya Kiriyama, Keita Matsumoto, Kazunori Yawata, Yoshiyuki Sasaki, Shinji Osada, Makoto Yamada
    Molecular and Clinical Oncology.2021;[Epub]     CrossRef
  • The antioxidant and anticancer potential of Ricinus communis L. essential oil nanoemulsions
    Asma Javanshir, Ehsan Karimi, Atieh Darchini Maragheh, Masoud Homayouni Tabrizi
    Journal of Food Measurement and Characterization.2020; 14(3): 1356.     CrossRef
  • Citrus aurantium L. bloom essential oil nanoemulsion: Synthesis, characterization, cytotoxicity, and its potential health impacts on mice
    Somayeh Navaei Shoorvarzi, Farzaneh Shahraki, Negin Shafaei, Ehsan Karimi, Ehsan Oskoueian
    Journal of Food Biochemistry.2020;[Epub]     CrossRef
  • Effect of Chemotherapy on Fatty Liver Occurrence in Breast and Gastrointestinal Cancer Patients: A Case-Controlled Study
    Payam Izadpanahi, Mahyar Mohammadifard, Tahmine Tavakoli, Najmeh Abbasi, Seyed Alireza Javadinia
    Hepatitis Monthly.2020;[Epub]     CrossRef
  • Other types of diffuse liver disease: is there a way to do it?
    Hilton Leao Filho, Camila Vilela de Oliveira, Natally Horvat
    Abdominal Radiology.2020; 45(11): 3425.     CrossRef
  • New in vitro highly cytotoxic platinum and palladium cyanoximates with minimal side effects in vivo
    Stephanie D. Dannen, Lauren Cornelison, Paul Durham, John E. Morley, Kiana Shahverdi, Junwei Du, Haiying Zhou, Leland C. Sudlow, Daniel Hunter, Matthew D. Wood, Mikhail Y. Berezin, Nikolay Gerasimchuk
    Journal of Inorganic Biochemistry.2020; 208: 111082.     CrossRef
  • Contrast-enhanced ultrasound compared with computed tomography, magnetic resonance imaging, and positron emission tomography-computed tomography for diagnosing liver metastases in people with newly diagnosed colorectal cancer
    Martin Lund, Tin Nadarevic, Thomas Abramovitz Bjerre, Henning Grønbaek, Frank Mortensen, Per Kragh Andersen
    Cochrane Database of Systematic Reviews.2020;[Epub]     CrossRef
  • Ethanolic Leaf Extract of Ocimum gratissimum Abrogates Methotrexate-induced Liver Injury in Albino Rats
    Elias Adikwu, Bonsome Bokolo, Othuke Bensandy Odeghe
    Asian Journal of Biological Sciences.2020; 13(2): 201.     CrossRef
  • Transitional Cell Carcinoma and Pseudocirrhosis— A Case Report and Review of the Literature
    Gilad Borisovsky, Daniel A. Goldstein, Noa Eliakim-Raz, Shlomit R. Tamir
    Journal of Gastrointestinal and Abdominal Radiology.2020; 3(S 01): S73.     CrossRef
  • Diagnostic imaging of a mass-shape hepatic steatosis in a dog treated with chemotherapy
    N Lee, J Seo, J Kim, J Yoon
    Veterinární medicína.2020; 65(5): 221.     CrossRef
  • A New Model for MR Evaluation of Liver Function with Gadoxetic Acid, Including Both Uptake and Excretion
    Daniel Truhn, Christiane K. Kuhl, Alexander Ciritsis, Alexandra Barabasch, Nils A. Kraemer
    European Radiology.2019; 29(1): 383.     CrossRef
  • Toxicokinetics and Biliary Excretion of N-Nitrosodiethylamine in Rat Supplemented with Low and High Dietary Proteins
    S. E. Kuyooro, J. K. Akintunde, F. C. Okekearu, E. N. Maduagwu
    Journal of Dietary Supplements.2019; 16(5): 506.     CrossRef
  • Quantitative magnetic resonance imaging evaluation of hepatic fat content with iron deposition: will it be disturbed?
    Qian Wang, Feng Ye, Peiqing Ma, Feng Chen, Yiqun Che, Xinming Zhao, Li Yang
    Journal of International Medical Research.2019; 47(5): 1958.     CrossRef
  • An imaging-based review of systemic therapies and associated toxicities in metastatic pancreatic cancer as per the 2018 ASCO guidelines: what every radiologist should know
    Daniel A. Smith, Bhanusupriya Somarouthu, Nikhil H. Ramaiya
    Abdominal Radiology.2019; 44(6): 2182.     CrossRef
  • Imatinib-induced hepatitis treated by corticosteroids in a patient with metastatic gastrointestinal stromal tumor
    Min Kyu Kang, Heon Ju Lee, Joon Hyuk Choi
    Yeungnam University Journal of Medicine.2019; 36(2): 155.     CrossRef
  • Clinical features of pseudocirrhosis in metastatic breast cancer
    Caspian Oliai, Michael L. Douek, Caelainn Rhoane, Abhishek Bhutada, Phillip S. Ge, Bruce A. Runyon, Xiaoyan Wang, Sara A. Hurvitz
    Breast Cancer Research and Treatment.2019; 177(2): 409.     CrossRef
  • CT and MR imaging of chemotherapy-induced hepatopathy
    Federica Vernuccio, Marco Dioguardi Burgio, Filippo Barbiera, Silvestro Cusmà, Giuseppe Badalamenti, Massimo Midiri, Valérie Vilgrain, Giuseppe Brancatelli
    Abdominal Radiology.2019; 44(10): 3312.     CrossRef
  • Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer
    Kaat De Clercq, Feifan Xie, Olivier De Wever, Benedicte Descamps, Anne Hoorens, An Vermeulen, Wim Ceelen, Chris Vervaet
    Scientific Reports.2019;[Epub]     CrossRef
  • Hepatic changes after treatment with oxaliplatin
    Leila Pereira Tenório, Michelle Ferraz Oliveira Miranda, Marcony Queiroz Andrade, Marcelo Antônio Nobrega Araujo
    Radiologia Brasileira.2019; 52(5): 343.     CrossRef
  • Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant Tumors
    Nirmitha I. Herath, Nathalie Berthault, Sylvain Thierry, Wael Jdey, Marie-Christine Lienafa, Françoise Bono, Patricia Noguiez-Hellin, Jian-Sheng Sun, Marie Dutreix
    Frontiers in Oncology.2019;[Epub]     CrossRef
  • Semicarbazide-sensitive amine oxidase activity levels in patients with acute lymphoblastic leukemia after cytotoxic chemotherapy
    Shatha Abdul Wadood AL‑Shammaree
    Beni-Suef University Journal of Basic and Applied Sciences.2018; 7(4): 683.     CrossRef
  • IDEAL-IQ in an oncologic population: meeting the challenge of concomitant liver fat and liver iron
    Sarah Eskreis-Winkler, Giuseppe Corrias, Serena Monti, Junting Zheng, Marinela Capanu, Simone Krebs, Maggie Fung, Scott Reeder, Lorenzo Mannelli
    Cancer Imaging.2018;[Epub]     CrossRef
  • 18F-FDG PET/CT in Local Ablative Therapies: A Systematic Review
    Erik H.J.G. Aarntzen, Linda Heijmen, Wim J.G. Oyen
    Journal of Nuclear Medicine.2018; 59(4): 551.     CrossRef
  • Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation
    Sophie Cayet, Jeremy Pasco, Fanny Dujardin, Marie Besson, Isabelle Orain, Anne De Muret, Elodie Miquelestorena-Standley, Julien Thiery, Thibaud Genet, Anne-Gwenn Le Bayon
    European Journal of Radiology.2017; 94: 180.     CrossRef
  • The Utilization of the Immune System in Lung Cancer Treatment: Beyond Chemotherapy
    Carmen Chan, Stephen Tsui, Bernard Law, Winnie So, Fiona Tang, Cho-Lee Wong
    International Journal of Molecular Sciences.2016; 17(3): 286.     CrossRef
  • Pseudocirrhosis in Gastric Cancer with Diffuse Liver Metastases after a Dramatic Response to Chemotherapy
    Seiichiro Mitani, Shigenori Kadowaki, Hiroya Taniguchi, Hisanori Muto, Kei Muro
    Case Reports in Oncology.2016; 9(1): 106.     CrossRef
  • Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective
    Danny Ngo, Jemianne Bautista Jia, Christopher S. Green, Anjalie T. Gulati, Chandana Lall
    Insights into Imaging.2015; 6(6): 665.     CrossRef

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

Include:

Chemotherapy induced liver abnormalities: an imaging perspective
Clin Mol Hepatol. 2014;20(3):317-326.   Published online September 25, 2014
Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:
Include:
Chemotherapy induced liver abnormalities: an imaging perspective
Clin Mol Hepatol. 2014;20(3):317-326.   Published online September 25, 2014
Close

Figure

  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Chemotherapy induced liver abnormalities: an imaging perspective
Image Image Image Image Image Image Image Image
Figure 1 Hepatic sinusoidal obstructive syndrome. Fifty six-year-old female with metastatic colon cancer. Chemotherapy with FOLFOX (Folinic Acid, 5 Flurouracil & Oxaliplatin) regimen was performed. This may lead to sinusoidal congestion, damage to the hepatic sinusoids with features of portal hypertension, splenomegaly and resultant thrombocytopenia. Coronal contrast enhanced CT (A) and axial contrast enhanced CT (B) demonstrate an enlarged spleen (arrow).
Figure 2 Hepatic sinusoidal obstructive syndrome. Fifty six-year-old male patient with acute myeloid leukemia on high dose chemotherapy after bone marrow transplantation. (A) Axial contrast enhanced CT images show mottled enhancement of the liver representing congestion due to veno-occlusive disease and hepatic vein thrombus (arrow). (B) There is a multilevel thrombus in IVC (arrow).
Figure 3 Pseudocirrhosis. Fifty six-year-old female underwent multiple cycles of chemotherapy for metastatic liver disease from breast cancer. Coronal (A) and axial (B) contrast enhanced CT images of the abdomen show a macronodular liver with fibrosis following completion of therapy. Patient had features of early hepatic decompensation.
Figure 4 Pseudocirrhosis. Forty seven-year-old female patient with previous history of chemotherapy for metastatic breast cancer. Axial (A) and sequential coronal (B and C) contrast enhanced CT images of the abdomen show a worsening of macronodular liver contour with enlarged spleen, consistent with pseudocirrhosis and signs of liver failure.
Figure 5 Steatosis patterns. All images are axial and coronal contrast enhanced CT. A and B demonstrate diffuse hepatic steatosis with focal sparing (white arrows), common pattern. C and D demonstrate diffuse steatosis without focal sparing, common pattern. E and F demonstrate geographic fatty change (white arrows), less common pattern.
Figure 6 Acute Hepatitis. Twenty nine-year-old female with lymphoma on cyclophosphamide and doxorubicin chemotherapy among other agents. Post treatment course was complicated by increase in liver enzymes. (A) Axial contrast enhanced CT images shows decreased hepatic attenuation with mild peri-portal edema consistent with acute hepatitis. (B) After three months, findings of hepatitis were resolved.
Figure 7 Hepatic Necrosis. Twenty-year-old female with acute myeloid leukemia, on COAP regimen (cyclophosphamide, oncovin, arabinosyl cytosine and prednisone). Post treatment course was complicated by increase in liver enzymes. (A) The pretreatment image shows no abnormality in liver (B) (C) After chemotherapy, coronal (B) and axial (C) contrast enhanced CT images demonstrate focal liver necrosis vs peliosis-centrilobular hemorrhagic necrosis of the liver (arrows).
Figure 8 Sixty two-year-old female after bone marrow transplantation. Coronal contrast enhanced CT demonstrates a filling defect in the portal vein (white arrow) compatible with portal vein thrombosis.
Chemotherapy induced liver abnormalities: an imaging perspective
Class Mechanism Examples
Alkylating agents DNA damage, not phase specific Platinums (cisplatin, carboplatin, oxaliplatin), nitrogen mustard derivatives (cytoxan, chlorambucil), alkyl sulfonates, nitrosourea (carmustine, lomustine), triazines
Anti-metabolites DNA/RNA replication in S phase of cell division Pyrimidine analogues (gemcitabine, 5-fluorouracil, capecitabine), methotrexate, gemcitabine-gemzar, 6 mercaptopurine, cytarabine
Anti-tumor antibiotics Interfere with enzymes needed for DNA replication Doxorubicin-adriamycin, danorubicin, mytomycin C, bleomycin
Isomerase inhibitors Interfere with enzymes needed for DNA replication Topotecan, irinotecan
Mitotic inhibitors Plant alkaloids that inhibit mitosis in tumor cells Taxanes-TAXOL, taxotere, vinca alkaloids (vincristine, vinblastine), etramustine - emcyt
Class Mechanism Examples
Hormone therapy Alter the action and production of hormones Anti-estrogens (tamoxifen), aromatase inhibitors (arimedex), progestins (megesterol acetate), estrogens
Immuno-therapy Stimulates immune system to recognize and attack cancer cells Monoclonal antibody(rituximab), immunotherapy: BCG, interleukin2, alpha interferon
immunomodulating: thalidomide, enalidomide
Differentiating agents Act on cancer cells to make them differentiate to normal cells Retinoids, tretinoin(ATRA, atralin)
bexarotene targretin, arsenic trioxide(arsenox)
Targeted therapies More specific than traditional chemotherapies; attack cells with mutant version of certain genes Imatinib-Gleevec, gefitinib
Iressam erlotinib
Tarceva, sunitinib
Sutent and bortezomib
Steroids Decreases inflammation and enhance effect of other drugs Prednisone
Methylprednisolone
Dexamethasone (decadron)
Pattern Features Hepatotoxic agents
SOS Microvascular injury and fibrosis weight gain, ascites, ↑bilirubin Oxaliplatin, 6-MP. dacarbazine, cyclophosphamide, and vincristine
Pseudocirrhosis Mimics macronodular cirrhosis on CT Gemcitabine, FOLFOX
In patients with metastatic breast and colon cancer
Steatosis Fat in hepatocytes mild transaminitis Irinotecan, oxaliplatin, and cetuximab, tamoxifen
Acute hepatitis ↑↑ AST/ALT Cisplatin
Pt appears acutely ill Vinblastine
Pt with prior hep B, C Rituximab
Hepatic necrosis Can present clinically with liver failure Mithramycin, L asparaginase, methotrexate
Table 1. Major classes of chemotherapeutic agents
Table 2. Other cancer therapies
Table 3. Patterns of hepatotoxicity with chemotherapy

SOS, sinusoidal obstructive syndrome; MP, mercaptopurine; CT, computed tomography; FOLFOX, folinic acid, 5 flurouracil & oxaliplatin; AST, aspartate Aminotransferase; ALT, alanine aminotransferase.